Ignite Creation Date:
2025-12-24 @ 12:24 PM
Ignite Modification Date:
2026-01-25 @ 4:00 AM
Study NCT ID:
NCT01120561
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2017-02-15
First Post:
2010-05-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Trastuzumab-MCC-DM1 in Patients With HER2- Positive Locally Advanced or Metastatic Breast Cancer
Sponsor:
Genentech, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-05
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2010-05-07
First Submit QC Date:
None
Study First Post Date:
2010-05-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-02-13
Last Update Post Date:
2017-02-15
Last Update Post Date Type:
ACTUAL